Cargando…

Primary malignant melanoma of the vagina: A case report

Malignant primary melanoma of the vagina (PMV) is a rare type of non-cutaneous melanoma often discovered in postmenopausal women. PMV has a very aggressive disease course and a poor prognosis. The best course of treatment is not presently agreed upon. In this report, we describe the case of a 68-yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Sticca, Giancarlo, Misheva, Bojana, Sebajang, Herawaty, Samouelian, Vanessa, Jamal, Rahima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505967/
https://www.ncbi.nlm.nih.gov/pubmed/37727370
http://dx.doi.org/10.1016/j.gore.2023.101266
_version_ 1785107019714265088
author Sticca, Giancarlo
Misheva, Bojana
Sebajang, Herawaty
Samouelian, Vanessa
Jamal, Rahima
author_facet Sticca, Giancarlo
Misheva, Bojana
Sebajang, Herawaty
Samouelian, Vanessa
Jamal, Rahima
author_sort Sticca, Giancarlo
collection PubMed
description Malignant primary melanoma of the vagina (PMV) is a rare type of non-cutaneous melanoma often discovered in postmenopausal women. PMV has a very aggressive disease course and a poor prognosis. The best course of treatment is not presently agreed upon. In this report, we describe the case of a 68-year-old woman presenting with a malignant PMV and its subsequent management. The patient presented with right vaginal pain, abnormal vaginal bleeding and a new vaginal mass. A PET scan identified a 28 × 38 mm hypermetabolic vaginal lesion, without nodal involvement or distant metastasis. A posterior exenteration type 2B was performed, including the anal mucosa. Sentinel lymph node dissection, vaginal and rectal resection as well as a terminal colostomy were also carried out. Final staging was FIGO stage III and T4bN1. Four months later, the patient presented with a recurrent vaginal bleed and intra-vaginal induration. Imaging revealed loco-reginal recurrence at the site of the primary malignancy with countless metastases. The patient opted for palliative care given the early disseminated recurrence and her multiple comorbidities. We review the treatment options for PMV, mainly the importance of surgery as the mainstay of treatment as well as the interest of adding checkpoint inhibitor immunotherapy or targeted therapy to the treatment plan. We also summarize the characteristics of PMV and its main prognostic factors.
format Online
Article
Text
id pubmed-10505967
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105059672023-09-19 Primary malignant melanoma of the vagina: A case report Sticca, Giancarlo Misheva, Bojana Sebajang, Herawaty Samouelian, Vanessa Jamal, Rahima Gynecol Oncol Rep Survey Article Malignant primary melanoma of the vagina (PMV) is a rare type of non-cutaneous melanoma often discovered in postmenopausal women. PMV has a very aggressive disease course and a poor prognosis. The best course of treatment is not presently agreed upon. In this report, we describe the case of a 68-year-old woman presenting with a malignant PMV and its subsequent management. The patient presented with right vaginal pain, abnormal vaginal bleeding and a new vaginal mass. A PET scan identified a 28 × 38 mm hypermetabolic vaginal lesion, without nodal involvement or distant metastasis. A posterior exenteration type 2B was performed, including the anal mucosa. Sentinel lymph node dissection, vaginal and rectal resection as well as a terminal colostomy were also carried out. Final staging was FIGO stage III and T4bN1. Four months later, the patient presented with a recurrent vaginal bleed and intra-vaginal induration. Imaging revealed loco-reginal recurrence at the site of the primary malignancy with countless metastases. The patient opted for palliative care given the early disseminated recurrence and her multiple comorbidities. We review the treatment options for PMV, mainly the importance of surgery as the mainstay of treatment as well as the interest of adding checkpoint inhibitor immunotherapy or targeted therapy to the treatment plan. We also summarize the characteristics of PMV and its main prognostic factors. Elsevier 2023-09-07 /pmc/articles/PMC10505967/ /pubmed/37727370 http://dx.doi.org/10.1016/j.gore.2023.101266 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Survey Article
Sticca, Giancarlo
Misheva, Bojana
Sebajang, Herawaty
Samouelian, Vanessa
Jamal, Rahima
Primary malignant melanoma of the vagina: A case report
title Primary malignant melanoma of the vagina: A case report
title_full Primary malignant melanoma of the vagina: A case report
title_fullStr Primary malignant melanoma of the vagina: A case report
title_full_unstemmed Primary malignant melanoma of the vagina: A case report
title_short Primary malignant melanoma of the vagina: A case report
title_sort primary malignant melanoma of the vagina: a case report
topic Survey Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505967/
https://www.ncbi.nlm.nih.gov/pubmed/37727370
http://dx.doi.org/10.1016/j.gore.2023.101266
work_keys_str_mv AT sticcagiancarlo primarymalignantmelanomaofthevaginaacasereport
AT mishevabojana primarymalignantmelanomaofthevaginaacasereport
AT sebajangherawaty primarymalignantmelanomaofthevaginaacasereport
AT samouelianvanessa primarymalignantmelanomaofthevaginaacasereport
AT jamalrahima primarymalignantmelanomaofthevaginaacasereport